The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes
Open accessAbstract
BACKGROUND: Cryptococcal meningitis (CM) is a leading cause of death in individuals infected with human immunodeficiency virus (HIV). Identifying factors associated with mortality informs strategies to improve outcomes. METHODS: Five hundred one patients with HIV-associated CM were followed prospectively for 10 weeks during trials in Thailand, Uganda, Malawi, and South Africa. South African patients (n = 266) were followed for 1 year. Similar inclusion/exclusion criteria were applied at all sites. Logistic regression identified baseline variables independently associated with mortality. RESULTS: Mortality was 17% at 2 weeks and 34% at 10 weeks. Altered mental status (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.7-5.9), high cerebrospinal fluid (CSF) fungal burden (OR, 1.4 per log10 colony-forming units/mL increase; 95% CI, 1.0-1.8), older age (>50 years; OR, 3.9; 95% CI, 1.4-11.1), high peripheral white blood cell count (>10 × 10(9) cells/L; OR, 8.7; 95% CI, 2.5-30.2), fluconazole-based induction treatment, and slow clearance of CSF infection were independently associated with 2-week mortality. Low body weight, anemia (hemoglobin <7.5 g/dL), and low CSF opening pressure were independently associated with mortality at 10 weeks in addition to altered mental status, high fungal burden, high peripheral white cell count, and older age. In those followed for 1 year, overall mortality was 41%. Immune reconstitution inflammatory syndrome occurred in 13% of patients and was associated with 2-week CSF fungal burden (P = .007), but not with time to initiation of antiretroviral therapy (ART). CONCLUSIONS: CSF fungal burden, altered mental status, and rate of clearance of infection predict acute mortality in HIV-associated CM. The results suggest that earlier diagnosis, more rapidly fungicidal amphotericin-based regimens, and prompt immune reconstitution with ART are priorities for improving outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A strong IFNγ response is indicative of a good prognosis in patients with cryptococcosis123,124.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationPark, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N. P., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,062
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 466
Self-citationJarvis, J. N., Lawn, S. D., Vogt, M., Bangani, N., Wood, R., & Harrison, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/597262 · Cited by 315
Self-citationKambugu, A., Meya, D. B., Rhein, J., O’Brien, M. P., Janoff, E. N., Ronald, A., Kamya, M. R., Mayanja‐Kizza, H., Sande, M. A., Bohjanen, P. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587667 · Cited by 299
Jarvis, J. N., Percival, A. L., Bauman, S. K., Pelfrey, J. M., Meintjes, G., Williams, G. N., Longley, N., Harrison, T. S., & Kozel, T. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir613 · Cited by 295
Self-citationMeya, D. B., Manabe, Y. C., Castelnuovo, B., Cook, B. A., Elbireer, A., Kambugu, A. D., Kamya, M. R., Bohjanen, P. R., & Boulware, D. R. (2010) · Clinical Infectious Diseases · doi:10.1086/655143 · Cited by 294
Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290
Self-citationCorticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
Scarborough, M., Gordon, S. B., Whitty, C. W. M., French, N., Njalale, Y., Chitani, A., Peto, T., Lalloo, D. G., & Zijlstra, E. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065711 · Cited by 278
Bicanic, T. A., Meintjes, G., Wood, R., Hayes, M., Rebe, K. B., Bekker, L., & Harrison, T. S. (2007) · Clinical Infectious Diseases · doi:10.1086/518607 · Cited by 271
Self-citation
Cited by
Sorted by citations
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Self-citationMaziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
Limper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30303-1 · Cited by 472
Self-citationCryptococcal meningitis: epidemiology, immunology, diagnosis and therapy
Williamson, P. R., Jarvis, J. N., Panackal, A. A., Fisher, M. C., Molloy, S. F., Loyse, A., & Harrison, T. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.167 · Cited by 487
Self-citationAntifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
Molloy, S. F., Kanyama, C., Heyderman, R. S., Loyse, A., Kouanfack, C., Chanda, D. M., Mfinanga, S., Temfack, E., Lakhi, S., Kivuyo, S. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710922 · Cited by 397
Self-citationTreatment strategies for cryptococcal infection: challenges, advances and future outlook
Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363
Mfinanga, S., Chanda, D. M., Kivuyo, S. L., Guinness, L., Bottomley, C., Simms, V. M., Chijoka, C., Masasi, A., Kimaro, G. D., Ngowi, B. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60164-7 · Cited by 250
Self-citationCryptococcosis diagnosis and treatment: What do we know now
Perfect, J. R., & Bicanic, T. A. (2014) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2014.10.003 · Cited by 256
Self-citationHIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment
Reoma, L. B., Smith, B., Reich, D. S., Quezado, M., & Nath, A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.149 · Cited by 221
Combinatorial strategies for combating invasive fungal infections
Spitzer, M., Robbins, N., & Wright, G. D. (2016) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 227
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda
Smith, K. D., Achan, B., Hullsiek, K. H., McDonald, T. R., Okagaki, L. H., Alhadab, A. A., Akampurira, A., Rhein, J., Meya, D. B., Boulware, D. R., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01299-15 · Cited by 191
The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis
Rolfes, M. A. R., Hullsiek, K. H., Rhein, J., Nabeta, H. W., Taseera, K., Schutz, C., Musubire, A. K., Rajasingham, R., Williams, D. A., Thienemann, F., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu596 · Cited by 195
Self-citationCryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing
Rajasingham, R., Wake, R. M., Beyene, T., Katende, A., Letang, E., & Boulware, D. R. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01238-18 · Cited by 190
Invasive fungal disease in humans: are we aware of the real impact?
Firacative, C. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200430 · Cited by 190
Rhein, J., Morawski, B. M., Hullsiek, K. H., Nabeta, H. W., Kiggundu, R., Tugume, L., Musubire, A., Akampurira, A., Smith, K. D., Alhadab, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00074-8 · Cited by 183
Cryptococcal Meningitis: Diagnosis and Management Update
Abassi, M., Boulware, D. R., & Rhein, J. (2015) · Current Tropical Medicine Reports · doi:10.1007/s40475-015-0046-y · Cited by 179
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis
Panackal, A. A., Wuest, S. C., Lin, Y.-C., Wu, T., Zhang, N., Kosa, P., Komori, M., Blake, A., Browne, S. K., Rosen, L. B., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004884 · Cited by 162
Jarvis, J. N., Meintjes, G., Bicanic, T., Buffa, V., Hogan, L., Mo, S., Tomlinson, G., Kropf, P., Noursadeghi, M., & Harrison, T. S. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004754 · Cited by 150
Self-citationPaim, K. F., Andrade-Silva, L. E., Fonseca, F. M., Ferreira, T. B., Mora, D. J., Andrade-Silva, J., Khan, A., Dao, A., Reis, E. C., de Almeida, M. T. G., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005223 · Cited by 125
Tugume, L., Ssebambulidde, K., Kasibante, J., Ellis, J. P., Wake, R. M., Gakuru, J., Lawrence, D. S., Abassi, M., Rajasingham, R., Meya, D. B., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00472-z · Cited by 140
Rhein, J., Hullsiek, K. H., Tugume, L., Nuwagira, E., Mpoza, E., Evans, E. E., Kiggundu, R., Pastick, K. A., Ssebambulidde, K., Akampurira, A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30127-6 · Cited by 124
Self-citationGushiken, A. C., Saharia, K., & Baddley, J. W. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.012 · Cited by 119
Bicanic, T. A., Bottomley, C., Loyse, A., Brouwer, A. E., Muzoora, C. K., Taseera, K., Jackson, A., Phulusa, J., Hosseinipour, M. C., van der Horst, C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01698-15 · Cited by 120
Self-citationTemfack, E., Bigna, J. J., Spijker, R., Loyse, A., Chiller, T. M., Pappas, P. G., Perfect, J. R., Sorell, T. C., Harrison, T. S., Cohen, J. F., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1243 · Cited by 118
Self-citationVidal, J. E., & Boulware, D. R. (2015) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652015000700008 · Cited by 106
Long term mortality and disability in Cryptococcal Meningitis: a systematic literature review.
Pasquier, E., Kunda, J. L., Beaudrap, P. D., Loyse, A., Temfack, E., Molloy, S. F., Harrison, T. S., & Lortholary, O. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix870 · Cited by 106
Self-citationBeale, M. A., Sabiiti, W., Robertson, E. J., Fuentes-Cabrejo, K. M., O’Hanlon, S. J., Jarvis, J. N., Loyse, A., Meintjes, G., Harrison, T. S., May, R. C., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003847 · Cited by 101
Self-citationCryptococcal therapies and drug targets: the old, the new and the promising
Coelho, C., & Casadevall, A. (2016) · Cellular Microbiology · doi:10.1111/cmi.12590 · Cited by 98
Li, S. S., Ogbomo, H., Mansour, M. K., Xiang, R. F., Szabo, L., Munro, F., Mukherjee, P. G., Mariuzza, R. A., Amrein, M., Vyas, J. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03014-4 · Cited by 90
Cryptococcal Disease in Diverse Hosts
Meya, D. B., & Williamson, P. R. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2311057 · Cited by 87
Jarvis, J. N., Leeme, T. B., Molefi, M., Chofle, A. A., Bidwell, G., Tsholo, K., Tlhako, N., Mawoko, N., Patel, R. K. K., Tenforde, M. W., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy515 · Cited by 86
Self-citationLetang, E., Müller, M. C., Ntamatungiro, A. J., Kimera, N., Faini, D., Furrer, H., Battegay, M., Tanner, M., Hatz, C., Boulware, D. R., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv046 · Cited by 81
Montoya, M. C., Magwene, P. M., & Perfect, J. R. (2021) · Journal of Fungi · doi:10.3390/jof7040260 · Cited by 85
Scriven, J. E., Rhein, J., Hullsiek, K. H., von Hohenberg, M., Linder, G., Rolfes, M. A. R., Williams, D. A., Taseera, K., Meya, D. B., Meintjes, G., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv067 · Cited by 75
Self-citation“Is there an emerging need for new antifungals?”
Perfect, J. R. (2016) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2016.1155554 · Cited by 76
Tenforde, M. W., Gertz, A. M., Lawrence, D. S., Wills, N. K., Guthrie, B. L., Farquhar, C., & Jarvis, J. N. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25416 · Cited by 75
Self-citationManzardo, C., Guardo, A. C., Letang, E., Plana, M., Gatell, J. M., & Miró, J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1029917 · Cited by 72
Fungal Infections of the Central Nervous System
Panackal, A. A., & Williamson, P. R. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000241 · Cited by 71
Beyene, T., Zewde, A., Balcha, A., Hirpo, B., Yitbarik, T., Gebissa, T., Rajasingham, R., & Boulware, D. R. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix613 · Cited by 68
Treatment for HIV-associated cryptococcal meningitis
Tenforde, M. W., Shapiro, A. E., Rouse, B., Jarvis, J. N., Li, T., Eshun‐Wilson, I., & Ford, N. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005647.pub3 · Cited by 66
Self-citationPeeling the onion: the outer layers of Cryptococcus neoformans
Agustinho, D. P., Miller, L., Li, L. X., & Doering, T. L. (2018) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760180040 · Cited by 62
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation
Rhein, J., Hullsiek, K. H., Evans, E. E., Tugume, L., Nuwagira, E., Ssebambulidde, K., Kiggundu, R., Mpoza, E., Musubire, A. K., Bangdiwala, A. S., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy122 · Cited by 61
Self-citationMukaremera, L., McDonald, T. R., Nielsen, J. N., Molenaar, C. J., Akampurira, A., Schutz, C., Taseera, K., Muzoora, C. K., Meintjes, G., Meya, D. B., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00046-19 · Cited by 61
Self-citationHurtado, J. C., Castillo, P., Fernandes, F., Navarro, M., Lovane, L., Casas, I., Quintó, L., Marco, F., Jordão, D., Ismail, M. R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43941-w · Cited by 65
Baddley, J. W., Chen, S. C. ‐., Huisingh, C., Benedict, K., DeBess, E. E., Galanis, E., Jackson, B. R., MacDougall, L., Marsden-Haug, N., Oltean, H. N., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab268 · Cited by 59
Loyse, A., Moodley, A., Rich, P. M., Molloy, S. F., Bicanic, T. A., Bishop, L., Rae, W. I. D., Bhigjee, A. I., Loubser, N., Michowicz, A., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.10.007 · Cited by 59
Self-citationHIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts
Tugume, L., Rhein, J., Hullsiek, K. H., Mpoza, E., Kiggundu, R., Ssebambulidde, K., Schutz, C., Taseera, K., Williams, D. A., Abassi, M., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy602 · Cited by 59
Self-citationLourens, A., Jarvis, J. N., Meintjes, G., & Samuel, C. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01683-14 · Cited by 56
Self-citationIntegrated therapy for HIV and cryptococcosis
Srichatrapimuk, S., & D, S. S. M. (2016) · AIDS Research and Therapy · doi:10.1186/s12981-016-0126-7 · Cited by 57
Cryptococcal meningoencephalitis: time for action
Stott, K. E., Loyse, A., Jarvis, J. N., Alufandika, M., Harrison, T. S., Mwandumba, H. C., Day, J., Lalloo, D. G., Bicanic, T. A., Perfect, J. R., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30771-4 · Cited by 56
Self-citationDay, J., Seet, Q., Thanh, L. T., Trieu, P. H., Van, A. D., Hoang, T. N., Chau, T. T. H., Lan, N. P. H., Châu, N. V. V., Ashton, P., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005628 · Cited by 54
Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis
Truong, M., Monahan, L. G., Carter, D. A., & Charles, I. G. (2018) · PeerJ · doi:10.7717/peerj.4761 · Cited by 57
Spec, A., Olsen, M. A. A., Raval, K., & Powderly, W. G. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw786 · Cited by 53
Modulating host immune responses to fight invasive fungal infections
Scriven, J. E., Tenforde, M. W., Levitz, S. M., & Jarvis, J. N. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.10.018 · Cited by 54
Self-citationMora, D. J., Fortunato, L. R., Andrade-Silva, L. E., Paim, K. F., Rocha, I. H., Vasconcelos, R. R., Silva-Teixeira, D. N., Nascentes, G. A. N., & Silva-Vergara, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120297 · Cited by 49
Dyal, J. W., Akampurira, A., Rhein, J., Morawski, B. M., Kiggundu, R., Nabeta, H. W., Musubire, A. K., Bahr, N. C., Williams, D. A., Bicanic, T. A., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myv104 · Cited by 50
Self-citationPanackal, A. A., Komori, M., Kosa, P. F., Khan, O. I., Hammoud, D. A., Rosen, L. B., Browne, S., Lin, Y.-C., Romm, E., Ramaprasad, C., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw739 · Cited by 50
Rajasingham, R., Meya, D. B., Greene, G., Jordan, A., Nakawuka, M., Chiller, T. M., Boulware, D. R., & Larson, B. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210105 · Cited by 49
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Thompson, G. R., Boulware, D. R., Bahr, N. C., Clancy, C. J., Harrison, T. S., Kauffman, C. A., Le, T. P., Miceli, M. H., Mylonakis, E. E., Nguyen, M. H., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac112 · Cited by 48
Self-citationCryptococcal Antigen Screening and Early Antifungal Treatment to Prevent Cryptococcal Meningitis
Kaplan, J. E., Vallabhaneni, S., Smith, R. M., Chideya-Chihota, S., Chehab, J., & Park, B. J. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000484 · Cited by 48
Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis
Rhein, J., Bahr, N. C., Morawski, B. M., Schutz, C., Zhang, Y., Finkelman, M., Meya, D. B., Meintjes, G., & Boulware, D. R. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu105 · Cited by 48
Self-citationNixon, G. L., McEntee, L., Johnson, A., Farrington, N., Whalley, S., Livermore, J., Natal, C., Washbourn, G., Bibby, J., Berry, N. G., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01909-17 · Cited by 48
Lawrence, D. S., Youssouf, N. F., Molloy, S. F., Alanio, A., Alufandika, M., Boulware, D. R., Boyer‐Chammard, T., Chen, T., Dromer, F., Hlupeni, A., et al. (2018) · Trials · doi:10.1186/s13063-018-3026-4 · Cited by 45
Self-citationDiagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults
Skipper, C. P., Abassi, M., & Boulware, D. R. (2019) · Journal of Fungi · doi:10.3390/jof5030065 · Cited by 72
Scriven, J. E., Graham, L. M., Schutz, C., Scriba, T. J., Wilkinson, K. A., Wilkinson, R. J., Boulware, D. R., Urban, B. C., Lalloo, D. G., & Meintjes, G. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw007 · Cited by 46
Self-citationConvergent microevolution of Cryptococcus neoformans hypervirulence in the laboratory and the clinic
Arras, S. D. M., Ormerod, K. L., Erpf, P. E., Espinosa, M. I., Carpenter, A. C., Blundell, R. D., Stowasser, S. R., Schulz, B. L., Tanurdžić, M., & Fraser, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-18106-2 · Cited by 47
Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System
Hamed, M. F., Araújo, G. R. D. S., Munzen, M. E., Reguera-Gómez, M., Epstein, C., Lee, H. H., Frasés, S., & Martinez, L. R. (2023) · mBio · doi:10.1128/mbio.02640-22 · Cited by 46
Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection
Campuzano, A., Castro-Lopez, N., Wozniak, K. L., Wager, C. M. L., & Wormley, F. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169347 · Cited by 42
Diagnosis and management of cryptococcal meningitis in HIV-infected adults
McHale, T. C., Boulware, D. R., Kasibante, J., Ssebambulidde, K., Skipper, C. P., & Abassi, M. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00156-22 · Cited by 49
Skolnik, K., Huston, S. M., & Mody, C. H. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.007 · Cited by 43
Patel, R. K. K., Leeme, T. B., Azzo, C., Tlhako, N., Tsholo, K., Tawanana, E. O., Molefi, M., Mosepele, M., Lawrence, D. S., Mokomane, M., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy267 · Cited by 42
Self-citationGassiep, I., McDougall, D. A. J., Douglas, J., Francis, R. S., & Playford, E. G. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12639 · Cited by 41
Differential diagnosis with other rapid progressive dementias
Geschwind, M. D., & Murray, K. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00020-9 · Cited by 43
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome
Sephton-Clark, P., Tenor, J. L., Toffaletti, D. L., Meyers, N., Giamberardino, C. D., Molloy, S. F., Palmucci, J. R., Chan, A. K., Chikaonda, T., Heyderman, R. S., et al. (2022) · mBio · doi:10.1128/mbio.02626-22 · Cited by 42
Self-citationGarvey, E. P., Sharp, A. D., Warn, P. A., Yates, C. M., & Schotzinger, R. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky242 · Cited by 39
Xu, J., Ganguly, A., Zhao, J., Ivey, M., Lopez, R., Osterholzer, J. J., Cho, C. S., & Olszewski, M. A. (2021) · mBio · doi:10.1128/mbio.01076-21 · Cited by 37
Hole, C. R., Wager, C. M. L., Mendiola, A. S., Wozniak, K. L., Campuzano, A., Lin, X., & Wormley, F. L. (2016) · Infection and Immunity · doi:10.1128/iai.00103-16 · Cited by 40
Hole, C. R., Lam, W. C., Upadhya, R., & Lodge, J. K. (2020) · mBio · doi:10.1128/mbio.03373-19 · Cited by 39
Nalintya, E., Meya, D. B., Lofgren, S. M., Hullsiek, K. H., Boulware, D. R., & Rajasingham, R. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001669 · Cited by 39
Lestner, J. M., McEntee, L., Johnson, A., Livermore, J., Whalley, S., Schwartz, J., Perfect, J. R., Harrison, T. S., & Hope, W. W. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00090-17 · Cited by 38
Self-citationEschke, M., Piehler, D., Schulze, B., Richter, T., Grahnert, A., Protschka, M., Müller, U., Köhler, G., Höfling, C., Roßner, S., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545689 · Cited by 37
Skipper, C. P., Schleiss, M. R., Bangdiwala, A. S., Hernandez-Alvarado, N., Taseera, K., Nabeta, H. W., Musubire, A. K., Lofgren, S. M., Wiesner, D. L., Rhein, J., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz864 · Cited by 37
Self-citationReuwsaat, J. C. V., Agustinho, D. P., Motta, H., Brown, H., Chang, A. L., Brent, M. R., Kmetzsch, L., & Doering, T. L. (2021) · mBio · doi:10.1128/mbio.03457-20 · Cited by 38
Neurological disorders in HIV in Africa: a review
Howlett, W. P. (2019) · African Health Sciences · doi:10.4314/ahs.v19i2.19 · Cited by 36
Risk Factors for Cryptococcal Meningitis: A Single United States Center Experience
Henao‐Martínez, A. F., Gross, L., McNair, B. K., McCollister, B. D., DeSanto, K., Montoya, J. G., Shapiro, L., & Beckham, J. D. (2016) · Mycopathologia · doi:10.1007/s11046-016-0048-x · Cited by 36
Villanueva-Lozano, H., Treviño-Rangel, R. D. J., González, G. M., Hernández-Rodríguez, P. A., Camacho-Ortiz, A., Castillo-Reyna, L., Galindo-Alvarado, S. G., & Martínez-Reséndez, M. F. (2018) · Infection · doi:10.1007/s15010-017-1059-3 · Cited by 35
Gupta‐Wright, A., Corbett, E. L., Wilson, D., van Oosterhout, J. J., Dheda, K. U. J., Huerga, H., Peter, J., Bonnet, M., Moyo, M., Grint, D. J., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002776 · Cited by 38
Self-citationOkurut, S., Boulware, D. R., Olobo, J. O., & Meya, D. B. (2020) · Mycoses · doi:10.1111/myc.13122 · Cited by 34
Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis
Mohamed, S. H., Nyazika, T. K., Ssebambulidde, K., Lionakis, M. S., Meya, D. B., & Drummond, R. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.804674 · Cited by 35
Ocansey, B. K., Otoo, B., Asamoah, I. E., Ganu, V. J., Berko, K. P., Oladele, O., Amankwa, E., Opoku‐Asare, B., Agyei, M. K., George, L., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac277 · Cited by 34
Meiring, S. T., Smidt, M. F.-D., Kularatne, R. S., Dawood, H., Govender, N. P., & GERMS-SA (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004865 · Cited by 34
Implementation and Operational Research
Vallabhaneni, S., Longley, N., Smith, M., Smith, R. M., Osler, M., Kelly, N., Cross, A., Boulle, A., Meintjes, G., & Govender, N. P. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000976 · Cited by 33
Self-citationEmerging concepts in HIV-associated cryptococcal meningitis
Lawrence, D. S., Boyer‐Chammard, T., & Jarvis, J. N. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000514 · Cited by 36
Self-citationLofgren, S. M., Hullsiek, K. H., Morawski, B. M., Nabeta, H. W., Kiggundu, R., Taseera, K., Musubire, A. K., Schutz, C., Abassi, M., Bahr, N. C., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix033 · Cited by 30
Self-citationNoninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis
Bóllela, V. R., Frigieri, G. H., Vilar, F. C., Spavieri, D. L., Tallarico, F. J., Tallarico, G. M., Andrade, R. A. P., de Haes, T. M., Takayanagui, O. M., Catai, A. M., et al. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176392 · Cited by 32
Williamson, P. R. (2016) · Macrophage · doi:10.14800/macrophage.1078 · Cited by 31
Innate host defenses against Cryptococcus neoformans
Hole, C. R., & Wormley, F. L. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5625-7 · Cited by 29
Chesdachai, S., Rajasingham, R., Nicol, M. R., Meya, D. B., Bongomin, F., Abassi, M., Skipper, C. P., Kwizera, R., Rhein, J., & Boulware, D. R. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz369 · Cited by 31
Rolfes, M. A. R., Rhein, J., Schutz, C., Taseera, K., Nabeta, H. W., Hullsiek, K. H., Akampuira, A., Rajasingham, R., Musubire, A. K., Williams, D. A., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv157 · Cited by 30
Self-citationde Sá, N. P., de Lima, C. M., Lino, C. I., Barbeira, P. J. S., Baltazar, L. D. M., Santos, D. A., de Oliveira, R. B., Mylonakis, E. E., Fuchs, B. B., & Johann, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02700-16 · Cited by 31
Metadata
- Authors
- Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., Kanyembe, C., Wilson, D., Hosseinipour, M. C., Brouwer, A. E., Limmathurotsakul, D., White, N., van der Horst, C., Wood, R., Meintjes, G., Bradley, J., Jaffar, S., & Harrison, T.
- Affiliations
- University of Cape Town (ZA)
- St George's, University of London (GB)
- University of California, San Francisco (US)
- Mbarara University of Science and Technology (UG)
- Edendale Hospital (ZA)
- Radboud University Medical Center (NL)
- Mahidol University (TH)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Jarvis, Joseph N.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-06
- Volume
- 58
- Issue
- 5
- Pages
- 736-745
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3922213
- OpenAlex
- W2101195119
- Cited by
- 367
- References
- 30
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 30 · 2023: 22 · 2022: 24 · 2021: 28 · 2020: 31 · 2019: 39 · 2018: 39 · 2017: 37 · 2016: 28 · 2015: 29 · 2014: 19
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Greater South Information System
- Funders
- Wellcome Trust (84323)
- National Institute for Health and Care Research (CL-2012-20-001)
- Medical Research Council (MR/K012126/1)
- National Institute of Allergy and Infectious Diseases (P30AI045008, P30AI050410)
- Fogarty International Center (D43TW001039)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- cryptococcal meningitis, HIV, mortality determinants, altered mental status, immune reconstitution inflammatory syndrome, amphotericin B, fluconazole, antiretroviral therapy, anemia, CSF opening pressure, age, white blood cell count
- MeSH terms
- Adult, Africa, Mental Disorders, Cerebrospinal Fluid, Female, Humans, Longitudinal Studies, Male, Prospective Studies, Risk Factors, Thailand, Colony Count, Microbial, Cohort Studies, HIV Infections, Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review